Literature DB >> 15451838

Registering CIHR-funded randomized controlled trials: a global public good.

David Moher1, Alan Bernstein.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  2004        PMID: 15451838      PMCID: PMC517861          DOI: 10.1503/cmaj.1041299

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  13 in total

Review 1.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

Review 2.  How useful are unpublished data from the Food and Drug Administration in meta-analysis?

Authors:  Catherine H MacLean; Sally C Morton; Joshua J Ofman; Elizabeth A Roth; Paul G Shekelle
Journal:  J Clin Epidemiol       Date:  2003-01       Impact factor: 6.437

3.  Getting to grips with Archie Cochrane's agenda.

Authors:  I Chalmers; K Dickersin; T C Chalmers
Journal:  BMJ       Date:  1992-10-03

4.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

Authors:  An-Wen Chan; Asbjørn Hróbjartsson; Mette T Haahr; Peter C Gøtzsche; Douglas G Altman
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

5.  Clinical trial registration: a statement from the International Committee of Medical Journal Editors.

Authors:  Catherine De Angelis; Jeffrey M Drazen; Frank A Frizelle; Charlotte Haug; John Hoey; Richard Horton; Sheldon Kotzin; Christine Laine; Ana Marusic; A John P M Overbeke; Torben V Schroeder; Hal C Sox; Martin B Van Der Weyden
Journal:  CMAJ       Date:  2004-09-14       Impact factor: 8.262

6.  Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research.

Authors:  An-Wen Chan; Karmela Krleza-Jerić; Isabelle Schmid; Douglas G Altman
Journal:  CMAJ       Date:  2004-09-28       Impact factor: 8.262

7.  Directory of registries of clinical trials.

Authors:  P J Easterbrook
Journal:  Stat Med       Date:  1992-02-15       Impact factor: 2.373

8.  Clinical-trial registration: a call for its implementation in Canada.

Authors:  D Moher
Journal:  CMAJ       Date:  1993-12-01       Impact factor: 8.262

9.  Redundancy, disaggregation, and the integrity of medical research.

Authors:  P Huston; D Moher
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

10.  Registering clinical trials.

Authors:  Kay Dickersin; Drummond Rennie
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

View more
  7 in total

Review 1.  Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1).

Authors:  Karmela Krleza-Jerić; An-Wen Chan; Kay Dickersin; Ida Sim; Jeremy Grimshaw; Christian Gluud
Journal:  BMJ       Date:  2005-04-23

2.  Nonpatentable drugs and the cost of our ignorance.

Authors:  Frédéric Calon
Journal:  CMAJ       Date:  2006-02-14       Impact factor: 8.262

3.  7th revision of the Declaration of Helsinki: good news for the transparency of clinical trials.

Authors:  Karmela Krleza-Jerić; Trudo Lemmens
Journal:  Croat Med J       Date:  2009-04       Impact factor: 1.351

4.  Increasing value and reducing waste: addressing inaccessible research.

Authors:  An-Wen Chan; Fujian Song; Andrew Vickers; Tom Jefferson; Kay Dickersin; Peter C Gøtzsche; Harlan M Krumholz; Davina Ghersi; H Bart van der Worp
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

5.  Investigator experiences with financial conflicts of interest in clinical trials.

Authors:  Paula A Rochon; Melanie Sekeres; John Hoey; Joel Lexchin; Lorraine E Ferris; David Moher; Wei Wu; Sunila R Kalkar; Marleen Van Laethem; Andrea Gruneir; Jennifer Gold; James Maskalyk; David L Streiner; Nathan Taback; An-Wen Chan
Journal:  Trials       Date:  2011-01-12       Impact factor: 2.279

6.  Clinical trial registration: the differing views of industry, the WHO, and the Ottawa Group.

Authors:  Karmela Krleza-Jerić
Journal:  PLoS Med       Date:  2005-10-18       Impact factor: 11.069

7.  The use of electronic data capture tools in clinical trials: Web-survey of 259 Canadian trials.

Authors:  Khaled El Emam; Elizabeth Jonker; Margaret Sampson; Karmela Krleza-Jerić; Angelica Neisa
Journal:  J Med Internet Res       Date:  2009-03-09       Impact factor: 5.428

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.